Be Biopharma

An artists concept of T cells attacking a cancer cell The T cells are in red while the cancer is light blue The cells are

Research

SNAP, CAR-M and BiTE: New immunotherapy approaches at SITC

Academics and industry folks from around the cancer world convened Nov. 1-5 at the SITC conference. Here are a few preclinical highlights.

Helen Floersh Nov 6, 2023 11:36am

graphic of a man with money identifying new ideas

Arch raises nearly $3B amid cratering biotech market

Jun 29, 2022 11:15am

Joanne Smith-Farrell

Be Bio closes Arch Venture-led $130M financing round

Apr 14, 2022 10:45am

desk with tablet and executives standing in background

Bluebird bio alums bolster Be Biopharma's leadership team

Mar 16, 2021 4:05pm

Be Biopharma debuts with $52M to advance B-cell therapies

Oct 22, 2020 7:00am